Back to search

Article

Integrative Transcriptomic Analysis Identifies Conserved Molecular Signatures and Drug Repurposing Candidates in Alzheimer’s Disease

2026-05-28

Abstract excerpt

<title>Abstract</title> <p>Background: Alzheimer’s disease (AD) is a progressive neurodegenerative illness characterized by cognitive deterioration and widespread molecular abnormalities. Despite much study, we still do not have effective disease-modifying treatments. Transcriptomic profiling is a powerful method to discover gene expression abnormalities causing AD and to find treatment targets. <h4>Objective:</...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
dddb5a9a-43ab-5d6c-9000-faf80fac5e24
DOI
10.21203/rs.3.rs-9676934/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Integrative Transcriptomic Analysis Identifies Conserved Molecular Signatures and Drug Repurposing Candidates in Alzheimer’s DiseaseDOI 10.21203/rs.3.rs-9676934/v1
Integrative Transcriptomics and Machine Learning Reveal a Robust Biomarker Signature for Alzheimer’s DiseaseSemantic proximity
Systematic analysis to identify transcriptome-wide dysregulation of Alzheimer's disease in genes and isoforms.Semantic proximity
Identification of molecular signatures and pathways to identify novel therapeutic targets in Alzheimer's disease: Insights from a systems biomedicine perspectiveSemantic proximity
A meta-analysis of bulk RNA-seq datasets identifies potential biomarkers and repurposable therapeutics against Alzheimer’s diseaseSemantic proximity
Identification of biomarkers and pathways to identify novel therapeutic targets in Alzheimer’s disease: Insights from a systems biomedicine perspectiveSemantic proximity
Comprehensive Analysis Reveals A Six-Gene Signature and Associated Drugs in Alzheimer DiseaseSemantic proximity
Common Dysregulated Pathways and Genes in Alzheimer’s, Parkinson’s, and Huntington’s Diseases: A Computational Analysis to Nominate Candidate Gene Targets for Drug RepurposingSemantic proximity
Transcriptome Meta-Analysis Suggests the Existence of Two Molecular Subtypes in Alzheimer’s DiseaseSemantic proximity
Screening novel drug candidates for Alzheimer’s disease by an integrated network and transcriptome analysisSemantic proximity
Integrated Bioinformatics and Ensemble Learning Reveal Diagnostic Modeling and Drug Discovery in Alzheimer’s DiseaseSemantic proximity
A single-cell atlas of the human brain in Alzheimer’s disease and its implications for personalized drug repositioningSemantic proximity
Identification of endoplasmic reticulum stress-associated genes and subtypes for prediction of Alzheimer’s disease based on interpretable machine learningSemantic proximity
Select a neighboring publication to make it the new centre.